Management of chronic depressive patients with residual symptoms

Changsu Han, Tzung Lieh Yeh, Masaki Kato, Soichiro Sato, Chia Ming Chang, Chi Un Pae

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Various clinical issues are involved in the appropriate diagnosis and proper treatment interventions for patients with major depressive disorder (MDD). Despite a number of diverse antidepressants for treating MDD now, response and remission rates following adequate trials of antidepressant intervention are still not satisfactory. Furthermore, a significant proportion of MDD patients have residual symptoms, which are associated with increased relapse and recurrence of MDD, leading to negative impacts on the clinical course and outcomes of MDD. Timely and appropriate decision-making regarding the proper management of such cases is required in our routine daily practice. These issues are illustrated and also framed by one MDD case with a complicated clinical course. This review paper may give physicians clinical insight into how we can effectively and properly evaluate and manage such patients in clinical practice.

Original languageEnglish
JournalCNS Drugs
Volume27
Issue numberSUPPL.1
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Major Depressive Disorder
Antidepressive Agents
Recurrence
Case Management
Decision Making
Physicians

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Han, C., Yeh, T. L., Kato, M., Sato, S., Chang, C. M., & Pae, C. U. (2013). Management of chronic depressive patients with residual symptoms. CNS Drugs, 27(SUPPL.1). https://doi.org/10.1007/s40263-012-0034-x

Management of chronic depressive patients with residual symptoms. / Han, Changsu; Yeh, Tzung Lieh; Kato, Masaki; Sato, Soichiro; Chang, Chia Ming; Pae, Chi Un.

In: CNS Drugs, Vol. 27, No. SUPPL.1, 01.05.2013.

Research output: Contribution to journalReview article

Han, C, Yeh, TL, Kato, M, Sato, S, Chang, CM & Pae, CU 2013, 'Management of chronic depressive patients with residual symptoms', CNS Drugs, vol. 27, no. SUPPL.1. https://doi.org/10.1007/s40263-012-0034-x
Han, Changsu ; Yeh, Tzung Lieh ; Kato, Masaki ; Sato, Soichiro ; Chang, Chia Ming ; Pae, Chi Un. / Management of chronic depressive patients with residual symptoms. In: CNS Drugs. 2013 ; Vol. 27, No. SUPPL.1.
@article{0c08a60b8dd141c884885b16d06d28a6,
title = "Management of chronic depressive patients with residual symptoms",
abstract = "Various clinical issues are involved in the appropriate diagnosis and proper treatment interventions for patients with major depressive disorder (MDD). Despite a number of diverse antidepressants for treating MDD now, response and remission rates following adequate trials of antidepressant intervention are still not satisfactory. Furthermore, a significant proportion of MDD patients have residual symptoms, which are associated with increased relapse and recurrence of MDD, leading to negative impacts on the clinical course and outcomes of MDD. Timely and appropriate decision-making regarding the proper management of such cases is required in our routine daily practice. These issues are illustrated and also framed by one MDD case with a complicated clinical course. This review paper may give physicians clinical insight into how we can effectively and properly evaluate and manage such patients in clinical practice.",
author = "Changsu Han and Yeh, {Tzung Lieh} and Masaki Kato and Soichiro Sato and Chang, {Chia Ming} and Pae, {Chi Un}",
year = "2013",
month = "5",
day = "1",
doi = "10.1007/s40263-012-0034-x",
language = "English",
volume = "27",
journal = "CNS Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",
number = "SUPPL.1",

}

TY - JOUR

T1 - Management of chronic depressive patients with residual symptoms

AU - Han, Changsu

AU - Yeh, Tzung Lieh

AU - Kato, Masaki

AU - Sato, Soichiro

AU - Chang, Chia Ming

AU - Pae, Chi Un

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Various clinical issues are involved in the appropriate diagnosis and proper treatment interventions for patients with major depressive disorder (MDD). Despite a number of diverse antidepressants for treating MDD now, response and remission rates following adequate trials of antidepressant intervention are still not satisfactory. Furthermore, a significant proportion of MDD patients have residual symptoms, which are associated with increased relapse and recurrence of MDD, leading to negative impacts on the clinical course and outcomes of MDD. Timely and appropriate decision-making regarding the proper management of such cases is required in our routine daily practice. These issues are illustrated and also framed by one MDD case with a complicated clinical course. This review paper may give physicians clinical insight into how we can effectively and properly evaluate and manage such patients in clinical practice.

AB - Various clinical issues are involved in the appropriate diagnosis and proper treatment interventions for patients with major depressive disorder (MDD). Despite a number of diverse antidepressants for treating MDD now, response and remission rates following adequate trials of antidepressant intervention are still not satisfactory. Furthermore, a significant proportion of MDD patients have residual symptoms, which are associated with increased relapse and recurrence of MDD, leading to negative impacts on the clinical course and outcomes of MDD. Timely and appropriate decision-making regarding the proper management of such cases is required in our routine daily practice. These issues are illustrated and also framed by one MDD case with a complicated clinical course. This review paper may give physicians clinical insight into how we can effectively and properly evaluate and manage such patients in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84886310643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886310643&partnerID=8YFLogxK

U2 - 10.1007/s40263-012-0034-x

DO - 10.1007/s40263-012-0034-x

M3 - Review article

C2 - 23709362

AN - SCOPUS:84886310643

VL - 27

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

IS - SUPPL.1

ER -